Collaborating Authors

A 62-Year-Old Paralyzed Man Sent Out His First Tweet With Brain Chip


A 62-year-old Australian man paralyzed following his diagnosis with amyotrophic lateral sclerosis (ALS) has become the first individual to send out a message on social media using a brain-computer interface, RT reported. Brain-computer interfaces (BCI) are the next big thing in technology. While some people like Elon Musk want to use it to enhance human experiences as early as next year, others such as Synchron, whose interface helped Australian Philip O'Keefe send out his first tweet, want to develop it as a prosthesis for paralysis and treat other neurological diseases such as Parkinson's disease in the future, the company said in a press release. Synchron's BCI works through its brain implant called Stentrode that does not require any brain surgery to be installed. Instead, the company leverages the intentional techniques that are commonly used to treat stroke to implant the Stentrode via the jugular vein, the press release said.

Brain chip deemed 'life-altering' after paralyzed men use it to control a computer with their MIND

Daily Mail - Science & tech

It may be the size of a paperclip, but this tiny brain implant has brought life back to men suffering with upper limb paralysis. Australia-based Synchron, a neurovascular bioelectronics medicine company, announced its Stentrode brain computer interface (BCI) has allowed patients to carry out tasks on a computer just by using their mind. Using the implant, patients achieved an average click accuracy of 92 percent and 93 percent and typing speeds of 14 and 20 characters per minute - without lifting a finger. The team is using blood vessels as a natural highway to the brain, which are laced with sensors that record activity. These signals are then sent through a telemetry unit to a small computer taped to the patient's chest, which interprets what actions the individual wants to perform on the nearby PC, such as texting, emailing and shopping online.

Elon Musk's Neuralink rival Synchron begins human trials of brain implant

Daily Mail - Science & tech

Elon Musk's Neuralink rival Synchron has begun human trials of its brain implant that lets the wearer control a computer using thought alone. The firm's Stentrode brain implant, about the size of a paperclip, will be implanted in six patients in New York and Pittsburgh who have severe paralysis. Stentrode will let patients control digital devices just by thinking and give them back the ability to perform daily tasks, including texting, emailing and shopping online. Although the implant has already been implanted and tested in Australian patients, the new clinical trial marks the first time it will be tested in the US. If successful, the Stentrode brain implant could be sold as a commercial product aimed at paralysis patients to regain their independence and quality of life.

New York company gets jump on Elon Musk's Neuralink with brain-computer interface in clinical trials

Daily Mail - Science & tech

Elon Musk might be well positioned in space travel and electric vehicles, but the world's second-richest person is taking a backseat when it comes to a brain-computer interface (BCI). New York-based Synchron announced Wednesday that it has received approval from the Food and Drug Administration to begin clinical trials of its Stentrode motor neuroprosthesis - a brain implant it is hoped could ultimately be used to cure paralysis. The FDA approved Synchron's Investigational Device Exemption (IDE) application, according to a release, paving the way for an early feasibility study of Stentrode to begin later this year at New York's Mount Sinai Hospital. New York-based Synchron announced Wednesday that it has received FDA approval to begin clinical trials of Stentrode, its brain-computer interface, beating Elon Musk's Neuralink to a crucial benchmark. The study will analyze the safety and efficacy of the device, smaller than a matchstick, in six patients with severe paralysis. Meanwhile, Musk has been touting Neuralink, his brain-implant startup, for several years--most recently showing a video of a monkey with the chip playing Pong using only signals from its brain.

FDA clears Synchron's brain-computer interface device for human trials


A company that makes an implantable brain-computer interface (BCI) has been given the go-ahead by the Food and Drug Administration to run a clinical trial with human patients. Synchron plans to start an early feasibility study of its Stentrode implant later this year at Mount Sinai Hospital, New York with six subjects. The company said it will assess the device's "safety and efficacy in patients with severe paralysis." Before such companies can sell BCIs commercially in the US, they need to prove that the devices work and are safe. The FDA will provide guidance for trials of BCI devices for patients with paralysis or amputation during a webinar on Thursday.